| Hans-Günter Meyer-Thompson | Opioide
Positive Topline Results for First-in-Class, Low-Abuse-Potential Opioid
Nektar Therapeutics has announced positive topline results from an oral human abuse potential (HAP) study of NKTR-181, a first-in-class opioid analgesic for chronic pain that reportedly carries significantly less abuse potential than oxycodone. (Medscape, 18.07.2017)